FILE PHOTO: Test tubes are seen in front of a displayed Abbvie logo in this illustration (Reuters) -AbbVie's drug met the main goal in a late-stage trial when tested in patients with early Parkinson's ...
Symptoms of Parkinson’s disease, such as tremors and stiffness, can make daily tasks difficult. A new drug has shown promise in alleviating symptoms. Tavapadon, a drug being tested to treat early ...
From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists have been able to identify patterns of neurodegeneration and create ...
Despite their differences, Alzheimer’s disease and Parkinson’s disease share several risk factors and mechanisms of neuronal damage. Both also feature a phase that precedes the appearance of symptoms ...
DUBLIN--(BUSINESS WIRE)--Prothena Corporation plc (NASDAQ:PRTA), today announced results from the Phase IIb PADOVA study conducted by partner Roche investigating prasinezumab in 586 people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results